| Row |
Level |
Rule Name |
Subject |
Property |
Value |
| 0 |
ERROR |
duplicate_definition |
DIDEO:00000065 |
IAO:0000115 |
An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has chemical inhibitors as a specified input.@en |
| 1 |
ERROR |
duplicate_definition |
DIDEO:00000068 |
IAO:0000115 |
An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has chemical inhibitors as a specified input.@en |
| 2 |
ERROR |
duplicate_definition |
DIDEO:00000066 |
IAO:0000115 |
An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has antibody inhibitors as a specified input.@en |
| 3 |
ERROR |
duplicate_definition |
DIDEO:00000069 |
IAO:0000115 |
An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has antibody inhibitors as a specified input.@en |
| 4 |
ERROR |
duplicate_definition |
DIDEO:00000182 |
IAO:0000115 |
a hydroxylation that has diclofenac as input and 4'-hydroxydiclofenac as output@en |
| 5 |
ERROR |
duplicate_definition |
DIDEO:00000191 |
IAO:0000115 |
a hydroxylation that has diclofenac as input and 4'-hydroxydiclofenac as output@en |
| 6 |
ERROR |
duplicate_label |
DIDEO:00000182 |
rdfs:label |
diclofenac 4'-hydroxylation@en |
| 7 |
ERROR |
duplicate_label |
DIDEO:00000191 |
rdfs:label |
diclofenac 4'-hydroxylation@en |
| 8 |
ERROR |
missing_ontology_description |
http://purl.obolibrary.org/obo/dideo.owl |
dc:description |
|
| 9 |
ERROR |
missing_ontology_title |
http://purl.obolibrary.org/obo/dideo.owl |
dc:title |
|
| 10 |
ERROR |
multiple_definitions |
DIDEO:00000075 |
IAO:0000115 |
@en |
| 11 |
ERROR |
multiple_definitions |
DIDEO:00000075 |
IAO:0000115 |
An evidence information content entity that is about a clinical drug trial that focusses on pharmacokinetics.@en |
| 12 |
WARN |
equivalent_class_axiom_no_genus |
DIDEO:00000025 |
OBI:0000312 |
DIDEO:00000026 |
| 13 |
WARN |
equivalent_class_axiom_no_genus |
DIDEO:00000033 |
OBI:0000312 |
DIDEO:00000032 |
| 14 |
WARN |
equivalent_class_axiom_no_genus |
DIDEO:00000036 |
OBI:0000312 |
DIDEO:00000035 |
| 15 |
WARN |
equivalent_class_axiom_no_genus |
DIDEO:00000038 |
OBI:0000312 |
DIDEO:00000037 |
| 16 |
WARN |
equivalent_class_axiom_no_genus |
DIDEO:00000049 |
IAO:0000136 |
DIDEO:00000046 |
| 17 |
WARN |
equivalent_class_axiom_no_genus |
DIDEO:00000125 |
OBI:1110060 |
DIDEO:00000020 |
| 18 |
WARN |
missing_definition |
DIDEO:00000029 |
IAO:0000115 |
|
| 19 |
WARN |
missing_definition |
DIDEO:00000090 |
IAO:0000115 |
|
| 20 |
WARN |
missing_definition |
DIDEO:00000096 |
IAO:0000115 |
|
| 21 |
WARN |
missing_definition |
DIDEO:00000126 |
IAO:0000115 |
|
| 22 |
WARN |
missing_obsolete_label |
DIDEO:00000085 |
rdfs:label |
realizes substrate role@en |
| 23 |
WARN |
missing_obsolete_label |
DIDEO:00000086 |
rdfs:label |
involves substrate@en |
| 24 |
INFO |
lowercase_definition |
DIDEO:00000027 |
IAO:0000115 |
there is some extended organism e
& there is some temporal region tr
& p occupies temporal region tr
& p occurs_in e
& c begins to exist during p
& there is some t
( t part-of tr & c located-in e at t )@en |
| 25 |
INFO |
lowercase_definition |
DIDEO:00000028 |
IAO:0000115 |
there is some extended organism e
& p1 occurs_in e
& p2 occurs_in e
& p1 immediately precedes p2@en |
| 26 |
INFO |
lowercase_definition |
DIDEO:00000075 |
IAO:0000115 |
@en |
| 27 |
INFO |
lowercase_definition |
DIDEO:00000149 |
IAO:0000115 |
a cultured cell population that is derived from hepatocytes isolated from a human being and that has undergone cryopreservation@en |
| 28 |
INFO |
lowercase_definition |
DIDEO:00000152 |
IAO:0000115 |
a cultured cell population that is derived from hepatocytes freshly isolated from a human being@en |
| 29 |
INFO |
lowercase_definition |
DIDEO:00000153 |
IAO:0000115 |
a cultured cell population that is derived from cells isolated from the liver of a transgenic organism@en |
| 30 |
INFO |
lowercase_definition |
DIDEO:00000154 |
IAO:0000115 |
a cultured cell population derived from hepatocytes, in which, during the culturing process, the cells occupy a region bound by two parallel plates made of gelled collagen@en |
| 31 |
INFO |
lowercase_definition |
DIDEO:00000155 |
IAO:0000115 |
a cultured cell population derived from cells isolated from human intestinal epithelium@en |
| 32 |
INFO |
lowercase_definition |
DIDEO:00000157 |
IAO:0000115 |
an immortal human liver-derived cell line cell that is part of the HepaRG cell line@en |
| 33 |
INFO |
lowercase_definition |
DIDEO:00000158 |
IAO:0000115 |
an immortal human liver-derived cell line cell that is part of the Fa2N-4 cell line@en |
| 34 |
INFO |
lowercase_definition |
DIDEO:00000159 |
IAO:0000115 |
an immortal human liver-derived cell line cell that is part of the HBG BC2 cell line@en |
| 35 |
INFO |
lowercase_definition |
DIDEO:00000160 |
IAO:0000115 |
a processed material that has a supernatant role resulting from high-speed centrifugation of a human liver S9 fraction@en |
| 36 |
INFO |
lowercase_definition |
DIDEO:00000161 |
IAO:0000115 |
a processed material that has a supernatant role resulting from high-speed centrifugation of a human intestine S9 fraction@en |
| 37 |
INFO |
lowercase_definition |
DIDEO:00000162 |
IAO:0000115 |
a processed material that has a supernatant role resulting from medium-speed centrifugation of a human liver homogenate@en |
| 38 |
INFO |
lowercase_definition |
DIDEO:00000163 |
IAO:0000115 |
a processed material that has a centrifuge pellet role resulting from high-speed centrifugation of a human intestine S9 fraction, which is derived from a single donor@en |
| 39 |
INFO |
lowercase_definition |
DIDEO:00000164 |
IAO:0000115 |
a processed material that has a centrifuge pellet role resulting from high-speed centrifugation of a pool of human liver S9 fractions, which is derived from multiple donors@en |
| 40 |
INFO |
lowercase_definition |
DIDEO:00000165 |
IAO:0000115 |
a processed material that has a centrifuge pellet role resulting from high-speed centrifugation of a human liver S9 fraction, which is derived from a single donor@en |
| 41 |
INFO |
lowercase_definition |
DIDEO:00000166 |
IAO:0000115 |
a processed material that has a centrifuge pellet role resulting from high-speed centrifugation of a pool of human intestine S9 fractions, which is derived from multiple donors@en |
| 42 |
INFO |
lowercase_definition |
DIDEO:00000167 |
IAO:0000115 |
a processed material that has a supernatant role resulting from medium-speed centrifugation of a human intestine homogenate@en |
| 43 |
INFO |
lowercase_definition |
DIDEO:00000168 |
IAO:0000115 |
a cultured cell that is part of a culture derived from an insect and has a recombit protein production host role@en |
| 44 |
INFO |
lowercase_definition |
DIDEO:00000169 |
IAO:0000115 |
a cultured cell of the species Escherichia coli that bears a recombit protein production host role@en |
| 45 |
INFO |
lowercase_definition |
DIDEO:00000170 |
IAO:0000115 |
a measurement datum that describes the decrease in activity of a transporter or enzyme in the presence of a compound from activity in the control experiment@en |
| 46 |
INFO |
lowercase_definition |
DIDEO:00000171 |
IAO:0000115 |
a hydroxylation that has midazolam as input and 1'-hydroxymidazolam as output@en |
| 47 |
INFO |
lowercase_definition |
DIDEO:00000172 |
IAO:0000115 |
a deethylation that has 7-ethoxyresorufin as input and resorufin as output@en |
| 48 |
INFO |
lowercase_definition |
DIDEO:00000173 |
IAO:0000115 |
a dehydrogenation that has nifedipine as input and has dehydronifedipine as output@en |
| 49 |
INFO |
lowercase_definition |
DIDEO:00000174 |
IAO:0000115 |
a hydroxylation that has bufuralol as input and 1'-hydroxybufurolol as output@en |
| 50 |
INFO |
lowercase_definition |
DIDEO:00000175 |
IAO:0000115 |
a hydroxylation that has omeprazole as input and has 5-hydroxyomeprazole as output@en |
| 51 |
INFO |
lowercase_definition |
DIDEO:00000176 |
IAO:0000115 |
a hydroxylation that has bupropion as input and 1-hydroxybupropion as output@en |
| 52 |
INFO |
lowercase_definition |
DIDEO:00000177 |
IAO:0000115 |
a hydroxylation that has paclitaxel as input and 6-alpha-hydroxypaclitaxel as output@en |
| 53 |
INFO |
lowercase_definition |
DIDEO:00000178 |
IAO:0000115 |
a deethylation that has phenacetin as input and acetaminophen as output@en |
| 54 |
INFO |
lowercase_definition |
DIDEO:00000179 |
IAO:0000115 |
a hydroxylation that has coumarin as input and has 7-hydroxycoumarin as output@en |
| 55 |
INFO |
lowercase_definition |
DIDEO:00000180 |
IAO:0000115 |
a hydroxylation that has testosterone as input and 6-beta-hydroxytestosterone as output@en |
| 56 |
INFO |
lowercase_definition |
DIDEO:00000181 |
IAO:0000115 |
a demethylation that has dextromethorphan as input and has dextrorphan as output@en |
| 57 |
INFO |
lowercase_definition |
DIDEO:00000182 |
IAO:0000115 |
a hydroxylation that has diclofenac as input and 4'-hydroxydiclofenac as output@en |
| 58 |
INFO |
lowercase_definition |
DIDEO:00000183 |
IAO:0000115 |
a target of material addition role that is borne by a cultured cell and, if realized, is realized in recombit protein production@en |
| 59 |
INFO |
lowercase_definition |
DIDEO:00000184 |
IAO:0000115 |
a count of administrations of a substance to an organism over a duration of 24 hours@en |
| 60 |
INFO |
lowercase_definition |
DIDEO:00000185 |
IAO:0000115 |
an immortal human liver-derived cell line cell that is part of the Hep G2 cell line@en |
| 61 |
INFO |
lowercase_definition |
DIDEO:00000186 |
IAO:0000115 |
a CHO cell that is a specified output of a transfection@en |
| 62 |
INFO |
lowercase_definition |
DIDEO:00000187 |
IAO:0000115 |
a Hep G2 cell that has a target of material addition role and is a specified input of a transfection@en |
| 63 |
INFO |
lowercase_definition |
DIDEO:00000188 |
IAO:0000115 |
a Caco-2 cell that is a specified output of a gene knockout that has specified input siRNA@en |
| 64 |
INFO |
lowercase_definition |
DIDEO:00000189 |
IAO:0000115 |
a 293-derived cell that is a specified output of a transfection@en |
| 65 |
INFO |
lowercase_definition |
DIDEO:00000190 |
IAO:0000115 |
a count of human beings from whom originate hepatocytes to be used in an investigation@en |
| 66 |
INFO |
lowercase_definition |
DIDEO:00000191 |
IAO:0000115 |
a hydroxylation that has diclofenac as input and 4'-hydroxydiclofenac as output@en |
| 67 |
INFO |
lowercase_definition |
DIDEO:00000192 |
IAO:0000115 |
a hydroxylation that has tolbutamide as input and 4-hydroxytolbutamide as output@en |
| 68 |
INFO |
lowercase_definition |
DIDEO:00000193 |
IAO:0000115 |
a glucuronosylation that has estradiol as input and has estradiol-3-glucuronide as output@en |
| 69 |
INFO |
lowercase_definition |
DIDEO:00000194 |
IAO:0000115 |
an MDCK cell that is the specified output of a transfection@en |
| 70 |
INFO |
lowercase_definition |
DIDEO:00000196 |
IAO:0000115 |
a glucuronosylation that has lamotrigine as input and has lamotrigine glucoronide as output@en |
| 71 |
INFO |
lowercase_definition |
DIDEO:00000197 |
IAO:0000115 |
a hydroxylation that has chlorzoxazone as input and 6-hydroxychlorzoxazone as output@en |